Drug Profile
Nifeviroc
Alternative Names: TD 0232Latest Information Update: 07 Jan 2016
Price :
$50
*
At a glance
- Originator TargetDrug
- Class Antiretrovirals; Antivirals; Small molecules
- Mechanism of Action CCR5 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 05 Aug 2009 Monogram Biosciences has been acquired by Laboratory Corporation of America Holdings
- 31 Dec 2007 Phase-I clinical trials in HIV infections in China (PO)